<DOC>
	<DOCNO>NCT02081066</DOCNO>
	<brief_summary>The reverse cholesterol transport ( RCT ) pathway , involve centripetal movement free cholesterol peripheral tissue , include vessel wall , liver represent primary mechanism HDL protect atherosclerosis may induce plaque regression . Recent data reveal capacity HDL efflux cholesterol macrophage , metric HDL function reflect initial step RCT , clinically relevant , display strong inverse association carotid intima-media thickness severity angiographic CAD ; observation independent HDL-C level . In human , Cholesteryl Ester Transfer Protein ( CETP ) , represent key protein RCT pathway mediate redistribution neutral lipid lipoprotein , identify potential therapeutic target atherosclerosis . It known CETP activity correlate HDL-C level represent key modulator ability whole plasma mediate free cholesterol efflux human macrophage . Recent study show 23 % endogenous plasma CETP activity variability explain plasma LDL-C ( 12.0 % ) , HDL-C ( 6.4 % ) TG ( 4.4 % ) whereas sex BMI account together 0.7 % variability . Scoring patient cardiovascular risk basis plasma lipid level ( TC , TG , LDL-C HDL-C ) , reveal patient high cardiovascular risk ( score â‰¥3 ) display mean endogenous plasma CETP activity 34 % . Therefore plasma CETP activity represent potent indicator cardiovascular risk patient metabolic disorder since integrates major independent risk factor . The objective study decipher relationship CETP , HDL efflux capacity development atherosclerosis human order identify CETP potent biomarker atherosclerosis distribution .</brief_summary>
	<brief_title>Identification CETP Marker Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Signed informed consent prior initiation study Men woman age 18 year Patients display least one abnormal plasma lipid parameter and/or receive lipidlowering therapy unchanged least 3 month . Current significant renal disease , include : nephrotic syndrome ; chronic renal failure and/or serum creatinine &gt; 1.7 x upper limit reference range ( ULRR ) Uncontrolled hypothyroidism define TSH &gt; 2 x ULRR Active hepatobiliary disease , include chronic hepatitis B hepatitis C infection ( confirmed serology ) ; aspartate aminotransferase ( AST/SGOT ) alanine aminotransferase ( ALT/SGPT ) &gt; 3.0 x ULRR Any prior history malignancy current cancer Current chronic acute inflammatory syndrome define CRP &gt; 10 mg/l</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>